Search for: "Prime Therapeutics, Inc." Results 1 - 20 of 23
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Sep 2018, 9:16 pm by Patent Docs
Par Pharmaceutical, Inc. 1-18-cv-01224; filed August 10, 2018 in the District Court of Delaware • Plaintiff: Horizon Therapeutics, LLC • Defendants: Par Pharmaceuticals, Inc., Par Pharmaceutical Companies, Inc. [read post]
20 Dec 2021, 8:21 am by Mark Astarita
Catenacci for insider trading in the securities of biotechnology company Five Prime Therapeutics, Inc. in advance of the company’s November 10, 2020 announcement that it…Read the Full Press ReleaseHave a securities law question? [read post]
8 Mar 2007, 8:18 am
Sirna Therapeutics, Inc., which, along with Alnylam Pharmaceuticals, Inc., bestride the RNAi patent estate, was swallowed up by pharmaceutical giant, Merck & Company, Inc.. [read post]
25 Mar 2012, 5:37 am by PritzkerLaw
E. coli O157:H7 in ground beef patties imported from Canada has prompted the recall of 16,800 pounds of hamburger products by Sysco Seattle Inc. of Seattle, Washington. [read post]
25 Mar 2012, 5:37 am by PritzkerLaw
E. coli O157:H7 in ground beef patties imported from Canada has prompted the recall of 16,800 pounds of hamburger products by Sysco Seattle Inc. of Seattle, Washington. [read post]
7 Mar 2012, 7:56 pm by Seyfarth Shaw LLP
District Court for the Northern District of California called “misleading” - in the case of In re CV Therapeutics, Inc., Securities Litigation, No. [read post]
6 Jun 2013, 12:15 am
The non-obviousness requirement prevents the patentability of drugs whose therapeutic properties are reasonably foreseen, but incurs in the same issue, as the predictability of therapeutic efficacy remains highly speculative until clinical trials are under way. [read post]
8 Aug 2011, 5:18 pm by FDABlog HPM
” With respect to labeling and therapeutic equivalence issues, King had requested that “FDA require ANDA sponsors of drug products containing auto-injectors to use the same physical description of an auto-injector, the same operating instructions, and the same illustrations contained in the RLD labeling,” and that “the same standard should apply in assessing therapeutic equivalence. . . . [read post]
25 Nov 2009, 3:00 am
Pro-Football, Inc (The IP Factor) (TTABlog) Brazil gets closer to listing US IP retaliation targets (IP tango)   Global Global - General Why the lack of ACTA transparency is not standard (Michael Geist) WIPO, a (rare) profitable UN agency, ventures into world of donors (IP Watch) WIPO Director wraps up official visit to India topped by meeting with Prime Minister (WIPO) Delegates look to April for consensus on development agenda coordination (IP Watch) International… [read post]
1 Jan 2019, 5:10 pm by Ben Vernia
  https://www.justice.gov/usao-ma/pr/united-therapeutics-agrees-pay-210-million-resolve-allegations-it-paid-kickbacks-through. [read post]
17 Aug 2009, 10:44 am
(Whitman, MA; Ann Calitri, President) Ag Therapeutics Incorporated (Boston, MA; Anthony Guarino, President) Ag Transportation, Inc. [read post]